References
- Gerlach J. Clozapin: Farmakologi, biokemi og klinik. Nord Psykiatr Tidsskr 1975; 29: 31–102
- Gerlach J, Koppelhus P, Helweg E, Monrad A. Clozapine and haloperidol in a single-blind crossover trial: Therapeutic and biochemical aspects in the treatment of schizophrenia. Acta Psychiatr Scand 1974; 50: 410–424
- Raptopoulos P, Gaind R. Clozapine (Leponex) in schizophrenia. Clin Trials Jl 1976; 2: 49–54
- Guirguis E, Voineskos G, Gray J, Schlieman E. Clozapine (Leponex) vs. chlorpromazine (Largactil) in acute schizophrenia (A doubleblind controlled study). Curr Ther Res 1977; 21: 707–719
- Shopsin B, Klein H, Aaronsom M, Collora M. Clozapine, chlorpromazine and placebo in newly hospitalised, acutely schizophrenic patients. Arch Gen Psychiat 1979; 36: 657–664
- Niskanen P, Achté K, Jaskari M ym. Results of a comparative doubleblind study with clozapine and chlorpormazine in the treatment of schizophrenic patients. Psychiatria Fennica 1974; 307–313
- Battegay R, et al. Results and Side Effects of Treatment with Clozapine (Leponex). Comprehens Psychiat 1977; 18: 423–428
- Claghorn JL, Abuzzaheb FS, Wang R ym. The current status of Clozapine. Psychopharmacol Bull 1983; 19: 138–140
- León C A. A 4-Year Follow-Up of a Controlled Clinical Trial. Acta Psychiat Scand 1979; 59: 471–480
- Steinbauer G, Diehl L W. Remarks to Clozapine. Nervenarzt 1980; 51: 373–374
- Erlandsen C. Utprøving av et nytt nevroleptikurn, Leponex (clozapin) hos schizofrene med lang sykehistorie. Nord Psykiatr Tidsskr 1981; 248–253
- Kirkegaard A, Hammershøy E, Østergård P. Nogle undersøgelser over bivirkninger ved langtidsbehandling (1–4 år) af 17 psykotiske patienter med Klozapin, (LeponexR). Nord Psykiatr Tidsskr 1982; 187–193
- Povlsen U, Juul, Noring U, Fog R, Gerlach J. Tolerability and therapeutic effect of clozapine: A retrospective investigation of 216 patients treated with clozapine for up to 12 years. Acta Psychiat Scand 1985; 71: 176–185
- Petersen E A. Klozapin-behandling af en 14-årig dreng i en psykotisk tilstand manifest fra 10-års alderen. Nord Psykiatr Tidsskr 1985; 39: 135–136
- Idänpään-Heikkilä J, Alhava E, Olkinuora M, Palva I. Clozapine and Agranulocytosis. Lancet 1975; II: 611
- Kuha S. The consequences of sudden stopping of clozapine in Finland. Proceed. VI World Congr. of Psychiatry. Honolulu, Hawai 1977, Abstract No. 813
- Cole OJ, Swett C, Pope H G. Psychopharmacology Update. Mc Lean Hosp J 1976; 1: 34–39
- Amsler HA, Teerenhovi L, Ym Barth E. Agranulocytosis in patients treated with clozapine. Acta Psychiatr Scand 1977; 56: 241–248
- Krupp P, Monka C. Agranulocytosis during Leponex treatment. Situation report March 31, 1982. Sandoz document April 26, 1982
- Miettinen E, Kuha S. The Clozapine Research of Chronic Schizophrenic In-Patients. 14th CINP-Congr. Florence 1984; 633, Abstract No. P-318